rivotra
zakłady farmaceutyczne polpharma s.a. - brimonidino tartratas - akių lašai (tirpalas) - 2 mg/ml - brimonidine
ghryvelin (previously macimorelin aeterna zentaris)
atnahs pharma netherlands b.v. - macimorelin acetatas - diagnostikos metodus, endokrininės sistemos - macimorelin - Šis vaistas yra skirtas tik diagnostikai. ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.
ephedrine hydrochloride sintetica
sintetica gmbh - efedrino hidrochloridas - injekcinis tirpalas - 10 mg/ml - ephedrine
ephedrine hydrochloride sintetica
sintetica gmbh - efedrino hidrochloridas - injekcinis tirpalas - 50 mg/ml - ephedrine
nuedexta
jenson pharmaceutical services limited - dekstrometorfanas, quinidine - neuro-elgesio apraiškos - kiti nervų sistemos vaistai - nuedexta skiriamas simptominiam pseudobulbaro poveikio (pba) gydymui suaugusiems. efektyvumas buvo tiriamas tik pacientams, kuriems būdinga amiotrofinė šoninė sklerozė arba išsėtinė sklerozė.
tisercin
egis pharmaceuticals plc - levomepromazinas - plėvele dengtos tabletės - 25 mg/ml; 25 mg - levomepromazine
gliclazide teva
teva b.v. - gliklazidas - modifikuoto atpalaidavimo tabletės - 60 mg - gliclazide
dizirel
sandoz d.d. - gliklazidas - modifikuoto atpalaidavimo tabletės - 60 mg - gliclazide
nocutil
niromed, uab - desmopresino acetatas - nosies purškalas (tirpalas) - 10 µg/išpurškime - desmopressin
xtandi
astellas pharma europe b.v. - enzalutamidas - prostatos navikai - endokrininė terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.